| Date Filed | Type | Description |
| 03/02/2023 |
4
| Ginascol John F (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Paid exercise price by delivering 6,859 shares
@ $99.77, valued at
$684.3k
Sold 943 shares
@ $100.7, valued at
$95k
|
|
| 02/22/2023 |
4
| Ginascol John F (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 14,270 shares
@ $0
Granted 56,275 options to buy
@ $106.24, valued at
$6M
|
|
| 12/15/2022 |
4
| Ginascol John F (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Sold 11,000 shares
@ $112.32, valued at
$1.2M
|
|
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/27/2021 |
4
| Ginascol John F (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Paid exercise price by delivering 29,588 shares
@ $128.13, valued at
$3.8M
Exercised 45,709 options to buy
@ $47, valued at
$2.1M
|
|
| 06/07/2021 |
4
| Ginascol John F (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Paid exercise price by delivering 1,768 shares
@ $106.9, valued at
$189k
|
|
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/03/2020 |
4
| Ginascol John F (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Paid exercise price by delivering 47,772 shares
@ $109.47, valued at
$5.2M
Exercised 12,012 options to buy
@ $47, valued at
$564.6k
Exercised 20,133 options to buy
@ $38.4, valued at
$773.1k
Exercised 39,953 options to buy
@ $44.4, valued at
$1.8M
|
|
| 06/05/2020 |
4
| Ginascol John F (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Paid exercise price by delivering 1,768 shares
@ $92.62, valued at
$163.8k
|
|
| 04/23/2020 |
4
| Ginascol John F (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Sold 23,966 shares
@ $95.5696, valued at
$2.3M
Sold 39,234 shares
@ $96.2591, valued at
$3.8M
Exercised 63,200 options to buy
@ $38.4, valued at
$2.4M
|
|
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2020 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
| 06/05/2019 |
4
| Ginascol John F (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 11,967 shares
@ $0
Granted 62,725 options to buy
@ $76.12, valued at
$4.8M
|
|
| 06/05/2019 |
3
| Ginascol John F (Executive Vice President) has filed a Form 3 on ABBOTT LABORATORIES |